ArticleNeuro-oncology2018

Synergy of vaccination and agonist OX40 treatment-toward a mechanism-driven combination of glioma immunotherapy.

Katrin Deumelandt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.